Aratana Therapeutics Inc (PETX)

7.51
0.17 2.30
NASDAQ : Health Care
Prev Close 7.34
Open 7.33
Day Low/High 7.20 / 7.72
52 Wk Low/High 2.56 / 19.99
Volume 689.67K
Avg Volume 535.30K
Exchange NASDAQ
Shares Outstanding 35.35M
Market Cap 242.13M
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Aratana Therapeutics Files For FDA Approval Of NOCITA® (bupivacaine Liposome Injectable Suspension)

Aratana Therapeutics Files For FDA Approval Of NOCITA® (bupivacaine Liposome Injectable Suspension)

Local Post-Operative Analgesia Provides Extended Pain Control

4 Stocks With Strong Technicals That You Should Watch

4 Stocks With Strong Technicals That You Should Watch

Here are four stocks with good technical strength pointing to higher prices.

Aratana Therapeutics (PETX) Is Strong On High Volume Today

Aratana Therapeutics (PETX) Is Strong On High Volume Today

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

Aratana Therapeutics Receives CMC Technical Section Complete Letter For Post-Operative Pain Therapeutic

Aratana Therapeutics Receives CMC Technical Section Complete Letter For Post-Operative Pain Therapeutic

Final Major Technical Section Complete Letter for NOCITA® (bupivacaine liposome injectable suspension)

2 Promising Biopharmas Reach Key Junctures

FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.

Aratana Therapeutics Granted FDA Approval Of ENTYCE® (capromorelin Oral Solution)

Aratana Therapeutics Granted FDA Approval Of ENTYCE® (capromorelin Oral Solution)

First-of-its-Kind Ghrelin Mimetic

Aratana Therapeutics (PETX) Is Strong On High Volume Today

Aratana Therapeutics (PETX) Is Strong On High Volume Today

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

2 Small-Cap Stocks That Could Win Big

Investing in small-cap names take a lot of research and patience, but they can also be very rewarding.

Aratana Therapeutics To Discuss Global Strategic Collaboration With Elanco Animal Health

Aratana Therapeutics To Discuss Global Strategic Collaboration With Elanco Animal Health

Conference Call Today at 6:00 p.m. ET

Aratana, Elanco Announce Global Strategic Collaboration

Aratana, Elanco Announce Global Strategic Collaboration

Agreement to expand Elanco's companion animal portfolio, extend global reach of GALLIPRANT® (grapiprant tablets) in canine osteoarthritis therapy

Aratana Therapeutics (PETX) Stock: Weak On High Volume Today

Aratana Therapeutics (PETX) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a weak on high relative volume candidate

Aratana Therapeutics (PETX) Is Today's Strong On High Volume Stock

Aratana Therapeutics (PETX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

Aratana Therapeutics (PETX) Stock Jumps Ahead of Drug Data Presentation

Aratana Therapeutics (PETX) Stock Jumps Ahead of Drug Data Presentation

Aratana Therapeutics (PETX) stock is spiking on Thursday afternoon as the pet therapeutics company said it will present pivotal efficacy and safety data about its galliprant tablets for dogs.

Aratana Therapeutics To Present GALLIPRANT® (grapiprant Tablets) Pivotal Data

Aratana Therapeutics To Present GALLIPRANT® (grapiprant Tablets) Pivotal Data

AAHA Session to Highlight Galliprant for the Control of Pain and Inflammation Associated with Osteoarthritis in Dogs

First Week of November 18th Options Trading For Aratana Therapeutics (PETX)

First Week of November 18th Options Trading For Aratana Therapeutics (PETX)

Investors in Aratana Therapeutics, Inc saw new options begin trading this week, for the November 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Strong On High Relative Volume: Aratana Therapeutics (PETX)

Strong On High Relative Volume: Aratana Therapeutics (PETX)

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

Aratana Therapeutics Files For Second FDA Approval

Aratana Therapeutics Files For Second FDA Approval

First-in-Class Ghrelin Agonist

Aratana Therapeutics Granted First FDA Approval

Aratana Therapeutics Granted First FDA Approval

Galliprant for the Control of Pain and Inflammation Associated with Osteoarthritis in Dogs

8 Stocks Under $10 to Trade for Big Gains

8 Stocks Under $10 to Trade for Big Gains

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

7 Stocks Under $10 Making Big Breakout Moves

7 Stocks Under $10 Making Big Breakout Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

8 Stocks Under $10 Making Big Moves Higher

8 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.